Stéphane Bancel
Chief Executive Officer, Moderna Therapeutics
Meet Stéphane Bancel
Prior to Moderna, Stéphane was CEO of bioMérieux and he has also held leadership positions at Eli Lilly. Moderna claims it can generate proteins needed to treat an array of diseases by turning cells into “drug factories” with custom-built strands of messenger RNA. In 2017, Stéphane was named Ernst & Young 2017 New England Entrepreneur of the Year.